Impact of glycemic control on heart rate variability in youth with type 1 diabetes: The SEARCH CVD study

Diabetes Technology and Therapeutics

Volumn 15, Issue 12, 2013, Pages 977-983

  Jaiswal, Mamta ^a   Fingerlin, Tasha E ^a   Urbina, Elaine M ^b   Wadwa, R Paul ^c   Talton, Jennifer W ^d   D'Agostino, Ralph B ^d   Hamman, Richard F ^a   Daniels, Stephen R ^e   Marcovina, Santica M ^f   Dolan, Larry M ^b   Dabelea, Dana ^a  

^a Food Science and Human Nutrition   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e University of Colorado Denver and Children s Hospital Colorado   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ELECTROCARDIOGRAM; EXTRASYSTOLE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PARASYMPATHETIC TONE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RR INTERVAL; SMOKING; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COLORADO; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LINEAR MODELS; MALE; OHIO; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; VASCULAR STIFFNESS;

EID: 84889632061     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0147     Document Type: Article

References (25)

1. Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: A meta-Analysis. Diabetes Care 2003;26:1895-1901
2. Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, Krähenbühl S, Diem P: Glycemic control and macrovascular disease in type 1 and 2 diabetes mellitus: Metaanalysis of randomized studies. Am Heart J 2006;152:27-38
3. The effect of intensive treatment of diabetes on the development and progression of long-Term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986
4. Reichard P, Nilsson BY, Rosenqvist U: The effect of longterm intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-309
5. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). The Diabetes Control and Complications Trial Research Group. Diabetologia 1998; 41:416-423
6. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U: Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): The Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 1991;230: 101-108
7. Ziegler D, Dannehl K, Wiefels K, Gries FA: Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients. Diabet Med 1992;9:622-629
8. Young RJ, Ewing DJ, Clarke BF: Nerve function and metabolic control in teenage diabetics. Diabetes 1983;32:142-147
9. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D: Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999;84:687-691
10. Jakobsen J, Christiansen JS, Kristoffersen I, Christensen CK, Hermansen K, Schmitz A, Mogensen CE: Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes. Diabetes 1988;37:452-455
11. SEARCH Study Group: SEARCH for Diabetes in Youth: A multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004;25:458-471
12. Kann L, Kinchen SA, Williams BI, Ross JG, Lowry R, Grunbaum JA, Kolbe LJ; State and Local YRBSS Coordinators. Youth Risk Behavior Surveillance System: Youth risk behavior surveillance -United States, 1999. MMWR CDC Surveill Summ 2000;49:1-32
13. Centers for Disease Control and Prevention: The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports [CD ROM]. Bethesda, MD: National Center for Health Statistics, 2005
14. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL: 2000 CDC growth charts for the United States: Methods and development. Vital Health Stat 11 2002;(246):1-190
15. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93:1043-1065
16. American Diabetes Association: Standards of medical care in diabetes -2012. Diabetes Care 2012;35(Suppl 1):S11-S63
17. Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH; DCCT/EDIC Research Group: Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009;119:2886-2893
18. Reichard P, Jensen-Urstad K, Ericsson M, Jensen-Urstad M, Lindblad LE: Autonomic neuropathy -A complication less pronounced in patients with type 1 diabetes mellitus who have lower blood glucose levels. Diabet Med 2000;17:860-866
19. Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K: Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes. Diabetes Care 2004;27:963-966
20. Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH; EURODIAB Prospective Complications Study Group: Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 2005;48:164-171
21. Young RJ, McIntyre CCA, Martin CN, Prescott RJ, Ewing DJ, Smith AF, Viberti G, Clarke BF: Progression of subclinical polyneuropathy of young patients with type I diabetes: Association with glycemic control and microangiopathy. Diabetologia 1986;29:156-161
22. Chen SR, Lee YJ, Chiu HW, Jeng C: Impact of glycemic control, disease duration, and exercise on heart rate variability in children with type 1 diabetes mellitus. J Formos Med Assoc 2007;106:935-942
23. Jaiswal M, Urbina EM, Wadwa RP, Talton JW, D'Agostino RB Jr, Hamman RF, Fingerlin TE, Daniels S, Marcovina SM, Dolan LM, Dabelea D: Reduced heart rate variability among youth with type 1 diabetes: The SEARCH CVD study. Diabetes Care 2013;36:157-162
24. Prasad A, Bekker P, Tsimikas S: Advanced glycation end products and diabetic cardiovascular disease. Cardiol Rev 2012;20:177-183
25. Vinik AI: The conductor of the autonomic orchestra. Front Endocrinol (Lausanne) 2012;3:71